Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Michigan Medical Genetics Laboratories, |
RCV000211021 | SCV000195948 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-11-03 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000503983 | SCV000591677 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000211021 | SCV000743238 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001723787 | SCV001157120 | benign | not provided | 2019-09-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000503983 | SCV002550249 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV000503983 | SCV001905722 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723787 | SCV001951806 | likely benign | not provided | no assertion criteria provided | clinical testing |